• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immunic Inc (NQ: IMUX )

    1.270 -0.110 (-7.97%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 187,079
    Open 1.340
    Bid (Size) 1.280 (3)
    Ask (Size) 1.320 (5)
    Prev. Close 1.380
    Today's Range 1.270 - 1.390
    52wk Range 0.9451 - 3.110
    Shares Outstanding 26,249,439
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
    IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal 
    Via News Direct

    Performance

    YTD
    -12.41%
    -12.41%
    1 Month
    -1.55%
    -1.55%
    3 Month
    +2.42%
    +2.42%
    6 Month
    +10.43%
    +10.43%
    1 Year
    -29.05%
    -29.05%

    More News

    Read More
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
    Via TheNewswire.com
    Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
    Via News Direct
    Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
    Via TheNewswire.com
    Immunic's Earnings Outlook
    Via Benzinga
    Immunic: Q3 Earnings Insights
    Via Benzinga
    A Preview Of Immunic's Earnings
    Via Benzinga
    Immunic "super excited" about latest PMS trial data
    Via News Direct
    Immunic And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What's Going On With Immunic Stock?
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Immunic CSO hails "great" progress with MS program
    Via News Direct
    Immunic CSO hails "great" progress with MS program
    Via TheNewswire.com
    Immunic "super excited" about latest PMS trial data
    Via TheNewswire.com
    Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate
    Via Benzinga
    Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
    Via News Direct
    Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
    Via TheNewswire.com
    Immunic CEO says Q2 results "couldn't be better"
    Via News Direct
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.